$NKTR NEKTAR THERAPEUTICS Insider Trading Week 50/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS in week 50/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 12.24 | 37,500 | 459,000 | 37,500 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 15,000 | 0 | 57,602 | 42.6 K to 57.6 K (+35.21 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 12.24 | 137,500 | 1,683,000 | 137,500 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Grant | A | 0.00 | 55,000 | 0 | 177,908 | 122.9 K to 177.9 K (+44.75 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Operati ... | Grant | A | 0.00 | 20,000 | 0 | 140,326 | 120.3 K to 140.3 K (+16.62 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 20,000 | 0 | 71,629 | 51.6 K to 71.6 K (+38.74 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 12.24 | 37,500 | 459,000 | 37,500 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Grant | A | 0.00 | 15,000 | 0 | 65,843 | 50.8 K to 65.8 K (+29.50 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 46,479 | 26.5 K to 46.5 K (+75.53 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 12.24 | 43,750 | 535,500 | 43,750 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Grant | A | 0.00 | 17,500 | 0 | 35,765 | 18.3 K to 35.8 K (+95.81 %) |